RET and medullary thyroid gland carcinoma: However, the stable incidence of MTC may reflect the consistency of its risk factors, predominantly linked to genetic mutations in the RET (REarranged during Transfection) proto-oncogene and its association with hereditary syndromes, such as multiple endocrine neoplasia type 2.